HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evelyne Defrêne Selected Research

lanifibranor

10/2020Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆.
1/2017The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Evelyne Defrêne Research Topics

Disease

2Fatty Liver
10/2020 - 01/2017
2Inflammation (Inflammations)
10/2020 - 01/2017
2Liver Cirrhosis (Hepatic Cirrhosis)
10/2020 - 01/2017
2Non-alcoholic Fatty Liver Disease
10/2020 - 01/2017
1Disease Progression
10/2020
1Hepatitis
10/2020
1Fibrosis (Cirrhosis)
01/2017
1Insulin Resistance
01/2017
1Obesity
01/2017
1Body Weight (Weight, Body)
01/2017

Drug/Important Bio-Agent (IBA)

2lanifibranorIBA
10/2020 - 01/2017
2Choline (Choline Chloride)IBA
10/2020 - 01/2017
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2020 - 01/2017
1CDAA (Randox)IBA
10/2020
1GW 501516IBA
10/2020
1Pioglitazone (Actos)FDA Link
10/2020
1Amino AcidsFDA Link
10/2020
1LipidsIBA
10/2020
1Fatty Acids (Saturated Fatty Acids)IBA
10/2020
1Protein Isoforms (Isoforms)IBA
10/2020
1Palmitic Acid (Hexadecanoic Acid)IBA
10/2020
1Fenofibrate (CiL)FDA LinkGeneric
10/2020
1Triglycerides (Triacylglycerol)IBA
01/2017
1Methionine (L-Methionine)FDA Link
01/2017
1Sucrose (Saccharose)IBA
01/2017